IndraLab

Statements


USP1 inhibits response PC cells therapeutic enzalutamide. 1 / 1
| 1

eidos
"Collectively , we showed that USP1 interacts with KDM4A and promotes its deubiquitination , ultimately leading to KDM4A stabilization , and inhibition of USP1 promotes the response of PC cells to therapeutic agent enzalutamide ( Figure7H ) ."